1980 Editorial dysfunction may be an inciting factor of arrhythmia burden in many . Conflicts of interest: none declared. of these patients, and should help guide the timing of any . intervention. . References 1. Schiebler GL, Gravenstein JS, Van Mierop LH. Ebstein’s anomaly of the tricuspid valve. It is difficult to draw generalized conclusions regarding the appro- . Translation of original description with comments. Am J Cardiol 1968;22:867–73. priateness of indications and timing for TV surgery from this more 2. Attenhofer Jost CH, Tan NY, Hassan A, Vargas ER, Hodge DO, Dearani JA, severe, and historic, cohort of patients with Ebstein’s anomaly. The Connolly H, Asirvatham SJ, McLeod CJ. Sudden death in patients with Ebstein anomaly. Eur Heart J 2018;39:1970–1977. risk factors of SD all point to late intervention and residual lesions as . 3. MacLellan-Tobert SG, Driscoll DJ, Mottram CD, Mahoney DW, Wollan PC, major causes, with a concerning rise of SD risk in the fourth decade Danielson GK. Exercise tolerance in patients with Ebstein’s anomaly. J Am Coll of life. However, early closure of the interatrial communication may . Cardiol 1997;29:1615–1622. 4. Attie F, Rosas M, Rijlaarsdam M, Buendia A, Zabal C, Kuri J, Granados N. The be all that is necessary for many symptomatic patients and, given the adult patient with Ebstein anomaly. Outcome in 72 unoperated patients. uncertain impact of previous iterations of surgery, which themselves Medicine (Baltimore) 2000;79:27–36. were quite abusive to the right ventricle, the slavish mantra that early . 5. Brown ML, Dearani JA, Danielson GK, Cetta F, Connolly HM, Warnes CA, Li Z, Hodge DO, Driscoll DJ; Mayo Clinic Congenital Heart Center. The outcomes of surgery is always better surgery is difficult to sustain with data. The operations for 539 patients with Ebstein anomaly. J Thorac Cardiovasc Surg 2008; avoidance of significant RV or LV systolic dysfunction and TV incom- . 135:1120–1136. petence, especially with associated PS, by surgical intervention has 6. Celermajer DS, Bull C, Till JA, Cullen S, Vassillikos VP, Sullivan ID, Allan L, Nihoyannopoulos P, Somerville J, Deanfield JE. Ebstein’s anomaly: presentation long been considered a reasonable goal of surgery in the myopathic and outcome from fetus to adult. J Am Coll Cardiol 1994;23:170–176. ventricles of these patients. Again, the road to hell may be paved with . 7. Brown ML, Dearani JA, Danielson GK, Cetta F, Connolly HM, Warnes CA, Li Z, good intentions. At the very least, these patients will require careful Hodge DO, Driscoll DJ. Effect of operation for Ebstein anomaly on left ventricu- lar function. Am J Cardiol 2008;102:1724–1727. arrhythmia surveillance after their operation, as it appears that their 8. Hassan A, Tan NY, Aung H, Connolly HM, Hodge DO, Vargas ER, Cannon BC, ‘unnatural history’ remains relatively poor. Of course, as with every . Packer DL, Asirvatham SJ, McLeod CJ. Outcomes of atrial arrhythmia radiofre- new operation, it is hoped that things may be different with the intro- . quency catheter ablation in patients with Ebstein’s anomaly. Europace 2018;20: duction of the ‘cone’ operation and its variants. In this regard, the . 535–540. . 9. Rydman R, Shiina Y, Diller GP, Niwa K, Li W, Uemura H, Uebing A, Barbero U, data from the Mayo clinic are sobering, and hopefully we will not see . Bouzas B, Ernst S, Wong T, Pennell DJ, Gatzoulis MA, Babu-Narayan SV. Major another phase of ‘bandwagon jumping’. Indeed, it may be decades . adverse events and atrial tachycardia in Ebstein’s anomaly predicted by cardio- before we know whether it truly makes a difference and, while any . vascular magnetic resonance. Heart 2018;104:37–44. 10. Shivapour JK, Sherwin ED, Alexander ME, Cecchin F, Mah DY, Triedman JK, call for a randomized trial is futile, we must surely remain somewhat Marx GR, del Nido PJ, Walsh EP. Utility of preoperative electrophysiologic stud- circumspect in surgical decision-making, and ever vigilant whether . ies in patients with Ebstein’s anomaly undergoing the Cone procedure. Heart operated or unoperated, in this complex group of patients. Rhythm 2014;11:182–186. doi:10.1093/eurheartj/ehx636 Corrigendum Online publish-ahead-of-print 26 October 2017 ................................................................................................ .................................................................. Corrigendum to: 2017 ESC/EACTS Guidelines for the management of valvular heart disease [Eur Heart J (2017) 38(36):2739–2786]. The authors of the above article wish to inform readers that the following correction has been made post-publication: footnote ‘f’ was removed from the ‘New IIa C recommendation’ section in the ‘What is new in the 2017 Valvular Heart Disease Guidelines?’ table on page 2783. V C The European Society of Cardiology 2017. All rights reserved. For permissions please email: email@example.com. Downloaded from https://academic.oup.com/eurheartj/article-abstract/39/21/1980/4566121 by Ed 'DeepDyve' Gillespie user on 21 June 2018
European Heart Journal – Oxford University Press
Published: Oct 26, 2017
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.
All for just $49/month
Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly
Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.
All the latest content is available, no embargo periods.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud